UNSPSC 51111752: Menogaril

This classification denotes an anthracycline antibiotic with the molecular formula C28H31NO10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8JSV4O30HQ, chemically known as 2,6-epoxy-2h-naphthaceno(1,2-b)oxocin-9,16-dione, 4-(dimethylamino)-3,4,5,6,11,12,13,14-octahydro-3,5,8,10,13-pentahydroxy-11-methoxy-6,13-dimethyl-, (2r-(2alpha,3beta,4alpha,5beta,6alpha,11alpha,13alpha))- but generally known as menogaril, which bears US NIH Compound Identifier 51370.

UNSPSC 51111752 Menogaril, a Commodity code, represents pharmaceutical products procured through state and local government health and public health agencies, though recent activity under this code shows minimal alignment with the nominal product scope. The recent state and local opportunities tagged to this code include antibiotic tablets (Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg) supplied through a cooperative purchasing vehicle, and naloxone units with drug deactivation systems procured for community health delivery. State and local health departments and county health agencies are the primary issuing bodies under this code, drawing on cooperative consortia such as MMCAP Infuse to aggregate purchasing power and leverage competitively awarded master contracts for pharmaceutical supply. The work involves ongoing pharmaceutical inventory replenishment on fixed contracts with multi-year renewal options, quarterly delivery schedules, and fixed-fee or unit-price pricing models.

Activity under the code appears concentrated in the Southeast and Midwest. Illinois Department of Public Health awarded a $2.999 million piggyback pharmaceutical contract through MMCAP Infuse to Chartwell Rx LLC on an IFB (Invitation for Bid) basis in August 2026, with a 12-month initial term and two renewal years. Seminole County, Florida released an IFB in June 2026 for annual procurement of 1,900 units of naloxone and 800 drug deactivation systems on a two-year contract with one-year renewal option, specifying quarterly delivery to the Seminole County Community Health Building and full vendor responsibility for shipping costs. Neither opportunity applied explicit set-asides or disadvantaged-enterprise restrictions, and both required standard compliance certifications (drug-free workplace, E-Verify, insurance coverage). The code shows low overall recent activity volume relative to other commodity pharmaceutical codes.